This device is commercially available for use in select international markets.
Designed for Complete Occlusion of the LAA
Atrial fibrillation is the biggest risk factor for ischaemic stroke. It has a crippling effect on patients’ lives and is one of the top health care costs in many countries.2-5 Current evidence suggests that percutaneous occlusion of the left atrial appendage (LAA) reduces the risk of thromboembolic complications associated with nonvalvular atrial fibrillation.1
We designed the AMPLATZER™ Cardiac Plug (ACP) to provide complete occlusion of the LAA at the orifice. Made of a flexible braided Nitinol mesh, the ACP allows for controlled, precise deployment and conformability to different appendage anatomies.
Designed for LAA closure
- Lobe conforms to the inner wall of the LAA and requires only a minimum depth of 10 mm for deployment, providing secure placement in a shallow landing zone.
- Self-orienting disc is designed to completely cover the orifice of the LAA.
- Device can be fully recaptured and repositioned for precise placement.
LEADING INNOVATION IN STRUCTURAL HEART DISEASE
The AMPLATZER™ Cardiac Plug is part of our structural heart occlusion portfolio. Our vision is to transform the treatment of structural heart disease by offering minimally invasive technologies designed for conformability and complete closure. Read more about the portfolio and our approach to structural heart disease.